# Rapiflex Distribution · 66-41 · CANADA — FDA import alert red lists: firms subject to detention without physical examination

For Rapiflex Distribution · 66-41 · CANADA, import alert is 66-41; import alert name is Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S; country is CANADA; product is OSMOPAK PLUS; product code is 61 M B J 11 Magnesium Sulfate (Anti-Convulsant), Human - Non/Rx Combination Ingredient, NonSterile Ointment; date published is 09/30/2009; address is 1795 Marie-Victorin St , Saint-Bruno, Quebec CANADA, verified against its source on 2026-09-16.

- **Firm:** Rapiflex Distribution _(verified: appears in the quote below)_
- **Import alert:** 66-41
- **Import alert name:** Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S.
- **Country:** CANADA _(verified: appears in the quote below)_
- **Address:** 1795 Marie-Victorin St , Saint-Bruno, Quebec CANADA _(verified: appears in the quote below)_
- **Date published:** 09/30/2009 _(verified: appears in the quote below)_
- **Product code:** 61 M B J 11 Magnesium Sulfate (Anti-Convulsant), Human - Non/Rx Combination Ingredient, NonSterile Ointment _(verified: appears in the quote below)_
- **Product:** OSMOPAK PLUS _(verified: appears in the quote below)_
- **FDA notes:** Shipper - This product is used as a drawing salve for the inflammation of subcutaneous tissues.; 3/26/1998 _(verified: appears in the quote below)_

## What the source says

> Rapiflex Distribution Date Published : 09/30/2009 1795 Marie-Victorin St , Saint-Bruno, Quebec CANADA 61 M B J 11 Magnesium Sulfate (Anti-Convulsant), Human - Non/Rx Combination Ingredient, NonSterile Ointment Date Published: 09/17/2019 Desc: OSMOPAK PLUS Notes: Shipper - This product is used as a drawing salve for the inflammation of subcutaneous tissues.; 3/26/1998

## Source

- https://www.accessdata.fda.gov/cms_ia/importalert_190.html

Last verified: 2026-09-16. Review by: 2026-11-15.
Part of [FDA import alert red lists: firms subject to detention without physical examination](https://referencesource.org/fda-import-alert-red-list/).